Invivyd, Inc. (IVVD) Dividend History

Invivyd, Inc. (IVVD) is a biotechnology company focused on developing innovative therapeutics and vaccines for infectious diseases, with an emphasis on viral pathogens. The company utilizes antibody-based and other advanced technologies to create treatments aimed at preventing and combating infectious illnesses.

1601 Trapelo Road, Waltham, MA, 02451
Phone: (781) 819-0080
Website: https://www.invivyd.com

Dividend History

Invivyd, Inc. currently does not pay dividends

Company News

Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights

Invivyd reported strong Q4 2024 revenue growth for its COVID-19 antibody PEMGARDA, and positive Phase 1 data for its next-generation candidate VYD2311. The company aims to achieve near-term profitability and continues to advance its pipeline.

GlobeNewswire Inc.
Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference

Invivyd, a biopharmaceutical company, announced its participation in the Guggenheim Securities Healthcare Innovation Conference, where it will host a fireside chat and 1x1 investor meetings.

GlobeNewswire Inc.
Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024

Invivyd, a biopharmaceutical company, announced that it will host a conference call on November 14, 2024, to discuss its financial results for the third quarter of 2024 and provide recent business highlights.

GlobeNewswire Inc.
Invivyd to Present PEMGARDA™ (pemivibart) Data at Infectious Disease Week (IDWeek) 2024

Invivyd, a biopharmaceutical company, announced upcoming presentations of data from its Phase 1 and Phase 3 clinical trials of pemivibart, an investigational monoclonal antibody for COVID-19 pre-exposure prophylaxis, at the IDWeek 2024 conference.

GlobeNewswire Inc.
Invivyd Announces its Addition to the Russell 2000® and Russell 3000® Indexes

WALTHAM, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that as part of the annual reconstitution of the Russell stock indexes, Invivyd will be included in the Russell 2000® Index and the broad-market Russell 3000® Index, effective at the open of U.S. equity markets today.

GlobeNewswire Inc.

Dividend data last updated 06/07/2025 03:31:47 UTC